Protein Folding and Misfolding Implications for Disease and Therapeutics
Abstract
Protein folding is a highly orchestrated process crucial for maintaining cellular homeostasis. However, aberrant protein folding can lead to misfolding, resulting in the accumulation of misfolded proteins and contributing to the pathogenesis of various diseases. This review explores the intricate mechanisms of protein folding, the consequences of misfolding, and the therapeutic strategies aimed at addressing protein misfolding disorders.
How to cite this article:
Jain A, Tyagi P. Protein Folding and Misfolding
Implications for Disease and Therapeutics. J Durg
Dis Dev 2023; 7(2): 21-26.
References
Anfinsen, C. B. (1973). Principles that Govern the Folding of Protein Chains. Science, 181(4096), 223–230.
Dobson, C. M. (2003). Protein folding and misfolding. Nature, 426(6968), 884–890.
Hartl, F. U., & Hayer-Hartl, M. (2009). Converging concepts of protein folding in vitro and in vivo. Nature Structural & Molecular Biology, 16(6), 574–581.
Balch, W. E., Morimoto, R. I., Dillin, A., & Kelly, J. W. (2008). Adapting proteostasis for disease intervention. Science, 319(5865), 916–919.
Chiti, F., & Dobson, C. M. (2006). Protein misfolding, functional amyloid, and human disease. Annual Review of Biochemistry, 75, 333–366.
Fink, A. L. (1999). Chaperone-mediated protein folding. Physiological Reviews, 79(2), 425–449.
Walter, S., & Buchner, J. (2002). Molecular chaperones— cellular machines for protein folding. Angewandte Chemie International Edition, 41(7), 1098–1113.
Selkoe, D. J. (2003). Folding proteins in fatal ways. Nature, 426(6968), 900–904.
Uversky, V. N. (2017). Intrinsically disordered proteins in overcrowded milieu: Membrane-less organelles, phase separation, and intrinsic disorder. Current Opinion in Structural Biology, 44, 18–30.
Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., ... & Stefani, M. (2002). Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature, 416(6880), 507–511.
Wang, S. S., Liu, K. N., Yang, A. K., & Sun, Y. (2016). Protein misfolding and aggregation in Alzheimer’s disease. Cellular and Molecular Neurobiology, 36(2), 203–213.
Knowles, T. P., Vendruscolo, M., & Dobson, C. M. (2014). The amyloid state and its association with protein misfolding diseases. Nature Reviews Molecular Cell Biology, 15(6), 384–396.
Fontana, A., de Laureto, P. P., Spolaore, B., Frare, E., & Picotti, P. (2004). Protein folding and misfolding in the cell. The Quarterly Review of Biophysics, 37(4), 337–397.
Gidalevitz, T., Ben-Zvi, A., Ho, K. H., Brignull, H. R., & Morimoto, R. I. (2006). Progressive disruption of cellular protein folding in models of polyglutamine diseases. Science, 311(5766), 1471–1474.
Lindquist, S., & Kelly, J. W. (2011). Chemical and biological approaches for adapting proteostasis to ameliorate protein misfolding and aggregation diseases—progress and prognosis. Cold Spring Harbor Perspectives in Biology, 3(9), a004507.
Taylor, J. P., Hardy, J., & Fischbeck, K. H. (2002). Toxic proteins in neurodegenerative disease. Science, 296(5575), 1991–1995.
Ross, C. A., & Poirier, M. A. (2004). Protein aggregation and neurodegenerative disease. Nature Medicine, 10(S7), S10–S17.
Nussbaum-Krammer, C. I., & Morimoto, R. I. (2014). Caenorhabditis elegans as a model system for studying non-cell-autonomous mechanisms in proteinmisfolding diseases. Disease Models & Mechanisms, 7(1), 31–39.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Author'sWe, the undersigned, give an undertaking to the following effect with regard to our article entitled
“_______________________________________________________________________________________________________________________________________________________________________________
________________________________________________________________________________” submitted for publication in (Journal title)________________________________________________ _______________________________________________________Vol.________, Year _________:-
1. The article mentioned above has not been published or submitted to or accepted for publication in any form, in any other journal.
2. We also vouchsafe that the authorship of this article will not be contested by anyone whose name(s) is/are not listed by us here.
3. I/We declare that I/We contributed significantly towards the research study i.e., (a) conception, design and/or analysis and interpretation of data and to (b) drafting the article or revising it critically for important intellectual content and on (c) final approval of the version to be published.
4. I/We hereby acknowledge ADRs conflict of interest policy requirement to scrupulously avoid direct and indirect conflicts of interest and, accordingly, hereby agree to promptly inform the editor or editor's designee of any business, commercial, or other proprietary support, relationships, or interests that I/We may have which relate directly or indirectly to the subject of the work.
5. I/We also agree to the authorship of the article in the following sequence:-
Authors' Names (in sequence) Signature of Authors
1. _____________________________________ _____________________________________
2. _____________________________________ _____________________________________
3. _____________________________________ _____________________________________
4. _____________________________________ _____________________________________
5. _____________________________________ _____________________________________
6. _____________________________________ _____________________________________
7. _____________________________________ _____________________________________
8. _____________________________________ _____________________________________
Important
(I). All the authors are required to sign independently in this form in the sequence given above. In case an author has left the institution/ country and whose whereabouts are not known, the senior author may sign on his/ her behalf taking the responsibility.
(ii). No addition/ deletion/ or any change in the sequence of the authorship will be permissible at a later stage, without valid reasons and permission of the Editor.
(iii). If the authorship is contested at any stage, the article will be either returned or will not be
processed for publication till the issue is solved.
